A
Akebia Therapeutics, Inc.
AKBA · NASDAQ · Healthcare · 234M
Price · close
$0.91
-1.39% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
7.1×
Enterprise value / EBITDAEV/EBITDA
12.2×
Free cash flow yieldFCF yield
29.2%
Return on equityROE
-16.4%
Operating margin
9.9%
Net debt / EBITDAbalance-sheet strength
1.4×
Interest coverage
1.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.